The estimated Net Worth of Venture Partners Ii Lp Medi... is at least $11.7 Milión dollars as of 25 March 2013. Venture Medi owns over 285,713 units of Tetraphase Pharmaceuticals stock worth over $11,736,252 and over the last 12 years Venture sold TTPH stock worth over $0.
Venture has made over 1 trades of the Tetraphase Pharmaceuticals stock since 2013, according to the Form 4 filled with the SEC. Most recently Venture bought 285,713 units of TTPH stock worth $1,999,991 on 25 March 2013.
The largest trade Venture's ever made was buying 285,713 units of Tetraphase Pharmaceuticals stock on 25 March 2013 worth over $1,999,991. On average, Venture trades about 285,713 units every 0 days since 2013. As of 25 March 2013 Venture still owns at least 540,592 units of Tetraphase Pharmaceuticals stock.
You can see the complete history of Venture Medi stock trades at the bottom of the page.
Over the last 12 years, insiders at Tetraphase Pharmaceuticals have traded over $24,668,458 worth of Tetraphase Pharmaceuticals stock and bought 8,437,280 units worth $39,426,767 . The most active insiders traders include Capital, Llc Armistice Capi..., Llc Fmr a John Gordon Freund. On average, Tetraphase Pharmaceuticals executives and independent directors trade stock every 27 days with the average trade being worth of $2,306,253. The most recent stock trade was executed by Jolla Pharmaceutical Co La on 28 July 2020, trading 3,737,360 units of TTPH stock currently worth $7,474,720.
Tetraphase Pharmaceuticals, Inc. engages in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also engages in the development of product candidate, eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Watertown, MA.
Tetraphase Pharmaceuticals executives and other stock owners filed with the SEC include: